WallStSmart

Welltower Inc (WELL)vsChiron Real Estate Inc. (XRN)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Welltower Inc generates 7847% more annual revenue ($11.77B vs $148.06M). WELL leads profitability with a 12.0% profit margin vs -3.9%. WELL appears more attractively valued with a PEG of 3.66. WELL earns a higher WallStSmart Score of 57/100 (C).

WELL

Buy

57

out of 100

Grade: C

Growth: 10.0Profit: 5.5Value: 2.0Quality: 6.5
Piotroski: 4/9Altman Z: 1.20

XRN

Hold

41

out of 100

Grade: D

Growth: 5.3Profit: 4.5Value: 4.0Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

WELLSignificantly Overvalued (-57.6%)

Margin of Safety

-57.6%

Fair Value

$131.92

Current Price

$216.91

$84.99 premium

UndervaluedFair: $131.92Overvalued

Intrinsic value data unavailable for XRN.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

WELL3 strengths · Avg: 9.7/10
Revenue GrowthGrowth
38.3%10/10

Revenue surging 38.3% year-over-year

EPS GrowthGrowth
157.9%10/10

Earnings expanding 157.9% YoY

Market CapQuality
$153.12B9/10

Large-cap with strong market position

XRN2 strengths · Avg: 9.0/10
Price/BookValuation
1.2x10/10

Reasonable price relative to book value

Operating MarginProfitability
25.1%8/10

Strong operational efficiency at 25.1%

Areas to Watch

WELL4 concerns · Avg: 2.3/10
Return on EquityProfitability
3.7%3/10

ROE of 3.7% — below average capital efficiency

PEG RatioValuation
3.662/10

Expensive relative to growth rate

P/E RatioValuation
105.3x2/10

Premium valuation, high expectations priced in

Altman Z-ScoreHealth
1.202/10

Distress zone — elevated risk

XRN4 concerns · Avg: 2.8/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$984.64M3/10

Smaller company, higher risk/reward

PEG RatioValuation
5.092/10

Expensive relative to growth rate

Return on EquityProfitability
-1.3%2/10

ROE of -1.3% — below average capital efficiency

Comparative Analysis Report

WallStSmart Research

Bull Case : WELL

The strongest argument for WELL centers on Revenue Growth, EPS Growth, Market Cap. Revenue growth of 38.3% demonstrates continued momentum.

Bull Case : XRN

The strongest argument for XRN centers on Price/Book, Operating Margin.

Bear Case : WELL

The primary concerns for WELL are Return on Equity, PEG Ratio, P/E Ratio. A P/E of 105.3x leaves little room for execution misses.

Bear Case : XRN

The primary concerns for XRN are EPS Growth, Market Cap, PEG Ratio.

Key Dynamics to Monitor

WELL profiles as a growth stock while XRN is a turnaround play — different risk/reward profiles.

XRN carries more volatility with a beta of 1.20 — expect wider price swings.

WELL is growing revenue faster at 38.3% — sustainability is the question.

WELL generates stronger free cash flow (282M), providing more financial flexibility.

Bottom Line

WELL scores higher overall (57/100 vs 41/100) and 38.3% revenue growth. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Welltower Inc

REAL ESTATE · REIT - HEALTHCARE FACILITIES · USA

Welltower Inc. is a real estate investment trust that invests in healthcare infrastructure.

Visit Website →

Chiron Real Estate Inc.

REAL ESTATE · REIT - HEALTHCARE FACILITIES · USA

Chiron Real Estate Inc. is a net-lease medical REIT that acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems.

Want to dig deeper into these stocks?